SynthesisBioMed research international2025
Revolutionizing Lung Cancer Detection: A High-Accuracy Machine Learning Framework for Early Diagnosis.
Synthesis in BioMed research international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung cancer is a deadly disease. According to a report of 2024, it is the primary reason for 1.82 million deaths. Given the high disease burden, early detection of lung cancer is crucial for improving survival rates and implementing effective strategies. This paper is aimed at conducting a systematic literature review and developing a highly accurate framework for predicting lung cancer effectively. Tollgate methodology has been used for systematic literature review, and quality assessment criteria were applied to select published articles relevant to the research questions. The paper investigates the effectiveness of machine learning in identifying patterns relevant to lung cancer prediction (Q1), examines the pros and cons of current predictive systems (Q2), compares the use of artificial intelligence in lung cancer prediction with traditional methods (Q3), and identifies key features that distinguish lung cancer from patient symptoms (Q4). Machine learning techniques were employed for the proposed framework. Two publicly available, distinct datasets containing clinical features were obtained. Then, the SelectKBest method was used for feature selection, and SMOTE was used to handle class imbalance. Our proposed framework includes a voting ensemble with random forest, support vector machine, and logistic regression with cross-validation. The results indicate an accuracy of 99% and 92.5% for the first and second datasets, respectively. This study's systematic literature review, based on four research questions and a machine learning model, exhibits high accuracy in predicting lung cancer.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.